“ EFFECT OF HOME BASED CHILD CARE ON DIARREAL DEAHTS IN A TRIBAL POPULATION: RESULT OF A FIELD TRIAL.”
ESPID Education, Abhijit Bharadwaj, 7661
ENTEROVIRUS AND HUMAN PARECHOVIRUS INFECTIONS ARE A MAJOR CAUSE OF FEVER OF UNKNOWN ORIGIN IN YOUNG CHILDREN
ESPID Education, Eveline P De Jong, 7664
DURATION OF SHEDDING OF HUMAN PARECHOVIRUS IN FAECES OF YOUNG CHILDREN AFTER SYMPTOMATIC INFECTION.
ESPID Education, Joanne G. Wildenbeest, 7666
ACTIVE SURVEILLANCE IS NEEDED FOR AMP-C β-LACTAMASE AND ESBL-PRODUCING ORGANISMS IN CHILDREN
ESPID Education, MILIND KHARE, 7678
SEVERE STREPTOCOCCAL GROUP A DISEASE IN CHILDREN WITH OR WITHOUT RISK FACTORS OF INVASIVE INFECTION: CLINICAL FEATURES AND EMM-TYPES DISTRIBUTION.
ESPID Education, Sophie Dugué, 7680
INVASIVE GROUP A STREPTOCOCCAL INFECTIONS IN THE VARICELLA VACCINE ERA.
ESPID Education, Julie Frere, 7681
HOSPITALIZATION DUE TO VARICELLA IN THE NETHERLANDS
ESPID Education, Hester de Melker, 7682
MOLECULAR AND CLINICAL CHARACTERIZATION OF ROTAVIRUS FROM DIARRHEAL INFANTS ADMITTED TO PEDIATRIC EMERGENY UNITS IN FRANCE, 2006-2010.
ESPID Education, Alexis de ROUGEMONT, 7683
VIRAL CO-INFECTIONS IN INFANTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP)
ESPID Education, Susanna Esposito, 7685
VARIATION IN A SURFACE-EXPOSED REGION OF THE MYCOPLASMA PNEUMONIAE P40 PROTEIN AS A CONSEQUENCE OF DNA RECOMBINATION BETWEEN REPMP5 ELEMENTS
ESPID Education, Emiel Spuesens, 7686
COMPARISON OF VIRULENCE TRAITS BETWEEN ESCHERICHIA COLI CLINICAL ISOLATES CAUSING EARLY NEONATAL SEPSIS AND THOSE COLLECTED FROM HEALTHY NEONATES.
ESPID Education, Elisabet Guiral, 7689
AETIOLOGY AND RISK FACTORS FOR HOSPITAL-ACQUIRED BACTERAEMIA IN CHILDREN ADMITTED TO A LONDON TERTIARY REFERRAL HOSPITAL
ESPID Education, A Perez-Lopez, 7690
ANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI CLINICAL ISOLATES CAUSING NEONATAL SEPSIS.
ESPID Education, Sara Soto, 7691
DECREASE OF VARICELLA ZOSTER VIRUS - ASSOCIATED PAEDIATRIC HOSPITALISATIONS AND COMPLICATIONS IN BAVARIA AFTER RECOMMENDATION FOR ROUTINE VARICELLA VACCINATION
ESPID Education, Andrea Streng, 7703
EVOLUTION OF THE MENINGOCOCCAL DISEASE´S INCIDENCE ON PAEDIATRIC NAVARRE´S POPULATION (NORTH OF SPAIN)
ESPID Education, Enrique Bernaola Iturbe, 7704
IMMUNOGENICITY AND PROTECTIVITY OF STAPHYLOCOCCUS AUREUS AND STREPTOCOCCUS PNEUMONIAE PROTEINS IN RELATION TO NASOPHARYNGEAL COLONIZATION AND VACCINATION
ESPID Education, S.M.P.J. Prevaes, 7705
NATURAL ANTIBODIES AGAINST SEVERAL PNEUMOCOCCAL VIRULENCE PROTEINS IN CHILDREN IN THE PRE-PNEUMOCOCCAL VACCINE-ERA: THE GENERATION R STUDY.
ESPID Education, Ankie Lebon, 7707
IMPACT OF THE 13-VALENT PNEUMOCOCCAL VACCINE ON THE INCIDENCE OF PAEDIATRIC EMPYEMA IN THE NORTH OF ENGLAND
ESPID Education, Mohamed Elemraid, 7708
PNEUMOCOCCAL CARRIAGE IN LIGURIA, ITALY, 7 YEARS AFTER PCV7 IMPLEMENTATION: ALMOST COMPLETE REPLACEMENT OF VACCINE SEROTYPES
ESPID Education, Filippo Ansaldi, 7710
RAPID REDUCTION IN INVASIVE PNEUMOCOCCAL DISEASE (IPD) AFTER INTRODUCTION OF PCV7 TO THE NATIONAL IMMUNIZATION PLAN (NIP) IN ISRAEL
ESPID Education, Noga Givon-Lavi, 7711
IMPACT OF PNEUMOCOCCAL VACCINATION IN DENMARK DURING THE FIRST 3 YEARS AFTER PCV7 INTRODUCTION IN THE CHILDHOOD IMMUNIZATION PROGRAMME
ESPID Education, Helene Ingels, 7712
RISK FACTORS FOR PREVALENT TUBERCULOSIS INFECTION AMONG CHILDREN IN GREENLAND
ESPID Education, Bolette Soborg, 7713
PRELIMINARY RESULTS OF THE PERFORMANCE OF IP-10 IN CHILDREN AT HIGH RISK FOR TUBERCULOSIS INFECTION
ESPID Education, Virginia Amanatidou, 7723
KINGELLA AS A CAUSE OF SEPTIC ARTHRITIS IN CHILDREN: THE BENEFIT OF MOLECULAR TECHNIQUES FOR MICROBIOLOGICAL DIAGNOSIS
ESPID Education, Jesus Saavedra-Lozano, 7724
IMPACT OF GEN-PROBE'S AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT TEST ON TUBERCULOSIS DIAGNOSIS IN CHILDREN
ESPID Education, Garyfallia Syridou, 7725
QUANTIFERON®-TB GOLD IN-TUBE PERFORMANCE FOR TUBERCULOSIS DIAGNOSIS IN 0-5 YEARS OF AGE CHILDREN
ESPID Education, Agathe de Lauzanne, 7726
IDENTIFICATION OF SERUM BIOMARKERS OF PAEDIATRIC TUBERCULOSIS USING SELDI
ESPID Education, Shea Hamilton, 7727
VALUE OF MOLECULAR DIAGNOSTIC TOOLS IN VIRAL RESPIRATORY ILLNESS IN HOSPITALIZED CHILDREN
ESPID Education, Janette Rahamat-Langendoen, 7728
PANDEMIC A/H1N1V INFLUENZA 2009 IN CHILDREN: A MULTICENTRIC BELGIAN SURVEY
ESPID Education, sophie Blumental, 7731
RETROSPECTIVE COMPARISON OF PANDEMIC INFLUENZA A/H1N1 (2009/2010) CLINICAL CHARACTERISTICS VERSUS SEASONAL INFLUENZA A (2007-2009) IN HOSPITALIZED CHILDREN IN BASEL, SWITZERLAND
ESPID Education, Ulrich Heininger, 7732
INCREASED INCIDENCE OF PERTUSSIS IN A TERTIARY CARE HOSPITAL IN MADRID (SPAIN) 2010. EPIDEMIOLOGICAL AND CLINICAL FEATURES OF THIS DISEASE
ESPID Education, Ana Malo de Molina Meléndez, 7734
A PRACTICAL APPROACH TO Q FEVER IN CHILDREN
ESPID Education, Ingeborg Bart, 7735
EXPECTED IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN INVASIVE BACTERIAL INFECTION RATE IN THE PEDIATRIC EMERGENCY DEPARTMENT
ESPID Education, Borja Gómez, 7742
CLINICAL CHARACTERISTICS OF SWINE FLU (H1N1) COMPARED TO OTHER RESPIRATORY VIRUSES IN THE UNITED KINGDOM
ESPID Education, Jesal Patel, 7746
DOSE-RANGING PAEDIATRIC STUDY: IDENTIFICATION OF A NOVEL MF59-ADJUVANTED 2A2B QUADRIVALENT INFLUENZA VACCINE
ESPID Education, Timo Vesikari, 7747
MF59®-ADJUVANTED H1N1 VACCINES IN CHILDREN 3-17 YEARS: SAFETY AND IMMUNOGENICITY FOLLOWING A 1-YEAR BOOSTER VACCINATION
ESPID Education, Maria Lattanzi, 7748
ANTIBODY PERSISTENCE IN CHILDREN VACCINATED WITH ONE DOSE OF ASO3-ADJUVANTED A/H1N1/2009 VACCINE AND THE EFFECT OF SEASONAL 2010-2011 INFLUENZA VACCINE
ESPID Education, Vladimir Gilca, 7749
IMMUNOGENICITY AND SAFETY OF INTRADERMAL INFLUENZA VACCINES WITH DIFFERENT AMOUNT OF ANTIGENS IN OTHERWISE HEALTHY CHILDREN
ESPID Education, Susanna Esposito, 7751
SAFETY OF A THREE SUBUNIT INFLUENZA VACCINE IN HEALTH CARE WORKERS IN KURDISTAN: A CROSS SECTIONAL STUDY
ESPID Education, Jafar Soltani, 7752
SURVEILLANCE OF VIRAL RESPIRATORY INFECTIONS IN THE EMERGENCY DEPARTMENT USING MICROARRAYS
ESPID Education, Sophia Kouni, 7764
BACTERIAL CELL WALL COMPONENT MURAMYL DIPEPTIDE SYNERGIZES WITH RESPIRATORY SYNCYTIAL VIRUS IN CYTOKINE PRODUCTION
ESPID Education, Marloes Vissers, 7766
PERTUSSIS AFTER END OF A MASS VACCINATION PROJECT - END OF THE VACCINATION HONEY- MOON
ESPID Education, Birger Trollfors, 7767
'DECLINE OF IgG-PERTUSSIS TOXIN IN UMBILICAL CORD BLOOD AND NEONATAL SERUM'
ESPID Education, N.A. van Welie, 7768
THE B-CELL RESPONSE TO PRIMARY AND BOOSTER DOSES OF MENACWY‑CRM VACCINE ADMINISTERED AT 2, 4 AND 12 MONTHS OF AGE
ESPID Education, Geraldine Blanchard-Rohner, 7769
MAINTENNANCE OF IMMUNE RESPONSE THROUGHOUT CHILDHOOD FOLLOWING SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINATION IN EARLY CHILDHOOD
ESPID Education, Ameneh Khatami, 7771
SYNCOPE IN MASS VACCINATION CAMPAIGNS IN THE NETHERLANDS; MENC IN 2002, HPV IN 2009, H1N1 IN 2009
ESPID Education, Patricia Vermeer-de Bondt, 7777
SPECIAL IMMUNIZATION SERVICE (SIS) IN PADOVA: 8 YEARS OF EXPERIENCE
ESPID Education, Teresa Mion, 7778
VACCINE UPTAKE DETERMINANTS IN THE NETHERLANDS
ESPID Education, Hester de Melker, 7779
EPIDEMIOLOGY OF THE UNVACCINATED: A BEHAVIOUR CHANGE COMMUNICATIONS FRAMEWORK AND TOOLKIT FOR THE WHO EUROPEAN REGION.
ESPID Education, Robb Butler, 7780
GENOTYPE DISTRIBUTION AND ROTAVIRUS GASTROENTERITIS HOSPITALIZATIONS FOUR YEARS AFTER VACCINATION IN SAO PAULO, BRAZIL
ESPID Education, Marco Safadi, 7784
HIGH PREVALENCE OF LOW VITAMIN D IN HIV VERTICALLY INFECTED CHILDREN LIVING IN IRELAND
ESPID Education, Patrick Gavin, 7790
NORMAL BONE MINERAL CONTENT AMONG HIV-UNINFECTED CHILDREN PERINATALLY EXPOSED TO ANTIRETROVIRALS
ESPID Education, Rosa Pino Ramírez, 7791
EFFECTS OF SIMPLIFICATION OF HAART IN HIV INFECTED CHILDREN
ESPID Education, Mar Santos-Sebastián, 7792
13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN CHILDREN PREVIOUSLY PARTIALLY IMMUNIZED WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7): PHASE 3, OPEN-LABEL TRIAL
ESPID Education, Sven-Arne Silfverdal, 7793
HIGHER STAPHYLOCOCCUS AUREUS COLONIZATION IN 11-MONTH-OLD CHILDREN FOLLOWING PCV-7 VACCINATIONS IN INFANCY
ESPID Education, S.M.P.J. Prevaes, 7794
LIMITED IMPACT OF THE 7-VALENT PNEUMOCOCCAL VACCINE ON PAEDIATRIC EMPYEMA IN THE NORTH OF ENGLAND
ESPID Education, Mohamed Elemraid, 7795
DEVELOPMENT OF A RAPID METHOD FOR IDENTIFICATION AND QUANTITATION OF PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES
ESPID Education, Manoj Kumar, 7797
HOSPITALIZED CHILDHOOD COMMUNITY ACQUIRED PNEUMONIA (CAP) IN BELGIUM: PNEUMOCOCCAL ETIOLOGY AND SEROTYPE DISTRIBUTION BASED ON CULTURE AND SEROTYPE SPECIFIC SEROLOGY.
ESPID Education, Iris De Schutter, 7799
IMMUNOGLOBULIN DEFICIENCY IN CHILDREN WITH HIB VACCINE FAILURE
ESPID Education, Clarissa Oeser, 7955
DETECTION OF FUSOBACTERIAL INFECTION IN A CULTURE-NEGATIVE BRAIN ABSCESS WITH 16S rRNA GENE PCR
ESPID Education, Christina Kortsalioudaki, 7957
TIMELINESS AND COMPLIANCE OF ROTAVIRUS VACCINATION IN AUSTRALIA
ESPID Education, MAJA GALIC, 7958
PROSPECTIVE, MULTINATIONAL ACTIVE HOSPITAL-BASED EPIDEMIOLOGIC SURVEILLANCE FOR IPD AND PNEUMONIA BURDEN AMONG CHILDREN IN BANGALORE SOUTH ZONE, BANGALORE, INDIA
ESPID Education, Ramalinge Gowda Nisarga, 7743
BUILDING UP AN EVIDENCE BASE FOR SUPPORTING HARMONISATION OF IMMUNISATION SCHEDULES IN EUROPE
ESPID Education, Pier Luigi Lopalco, 4855
DIFFICULTIES OF EMEA FOR REGISTRATION INDUCED BY THE DIFFERENT SCHEDULES IN EUROPE
ESPID Education, Pieter Neels, 4854
INFANT VACCINE SCHEDULES: MAY VACCINE IMMUNOLOGY SHOW US THE WAY FORWARD?
ESPID Education, Claire-Anne Siegrist, 4853
CHILDREN WITH FEVER: CHALLENGES FOR PAEDIATRICIANS AND METHODOLOGISTS
ESPID Education, Rianne Oostenbrink, 4847
DIAGNOSTIC VALUE OF SYMPTOMS AND SIGNS IN ASSESSING THE RISK FOR SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH FEVER WITHOUT SOURCE
ESPID Education, Matthew Thompson, 4848
INTERPRETATION OF A SINGLE LABORATORY TEST TO DISCRIMINATE BETWEEN VIRAL AND BACTERIAL INFECTIONS IN CHILDREN WITH FEVER WITHOUT SOURCE?
ESPID Education, Alain Gervaix, 4849
CHILDREN WITH FEVER WITHOUT SOURCE: LOOKING FOR THE MARKER
ESPID Education, Octavio Ramilo, 4851
HOW TO MANAGE RESISTANT GRAM+ ORGANISM INFECTIONS IN CHILDREN?
ESPID Education, Emmanuelle Varon & Philippe Ovetchkine, 4845
COLIMYCIN
ESPID Education, Robert Cohen, 4844
PENEMS
ESPID Education, Xavier Durrmeyer, 4843
DAPTOMYCIN
ESPID Education, Christian Chidiac, 4842
NEW AND OLD ANTIBIOTICS TO TREAT RESISTANT BACTERIA: LINEZOLID
ESPID Education, Celine Pulcini, 4841
Clinical Cases
ESPID Education, Emmanuel Grimprel, 5244
Expecting a baby... at home or abroad?
ESPID Education, Catherine Weil-Olivier, 5245
IMMUNIZATION IN SPECIAL CIRCUMSTANCES: FROM GUIDELINES TO PATIENT CARE, THE INFOVAC EXPERT NETWORK MODEL
ESPID Education, Claire-Anne Siegrist, 4840
Rare and not so rare! Do I know?
ESPID Education, Ulrich Heininger, 5243
HOW TO MANAGE RESISTANT GRAM- ORGANISM INFECTIONS IN CHILDREN?
ESPID Education, Shai Ashkenazi and Edouard Bingen , 4838
Immunity or autoimmunity? This is often the question!
ESPID Education, Claire-Anne Siegrist, 5246
INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN: A PRIMARY IMMUNODEFICIENCY ?
ESPID Education, Capucine Picard, 4835
DIAGNOSIS & MANAGEMENT OF INFECTIONS IN CHILDREN WITH IMMUNE DEFICIENCIES
ESPID Education, Andrew Cant, 4836
INFECTIONS IN PATIENTS ON THE NEW BIOLOGICAL IMMUNOSUPPRESSIVE AGENTS
ESPID Education, Mario Abinun, 4837
MDR-TB MANAGEMENT IN A 7-MONTH-OLD CHINESE GIRL
ESPID Education, Luis Gonzalez-Granado, 3700
CASE HSV-Neonate
ESPID Education, Michael Buettcher, 3701
CENTRAL VENOUS CATHETERS-RELATED INFECTIONS
ESPID Education, Simone Cesaro, 3568
RECIDIVANT NEONATAL ESCHERICHIA COLI MENINGITIS
ESPID Education, Anja Radsel, 3702
THE APPROACH TO A CHILD WITH NEUTROPENIC FEVER
ESPID Education, Itzhak Levy, 3567
TREATING SEVERE STAPHYLOCOCCAL INFECTIONS
ESPID Education, Sheldon Kaplan, 3566
INTRODUCTION AND AIM OF THE WORKSHOP
ESPID Education, Carlo Giaquinto, 3564

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings